Proteomics

Dataset Information

Rituximab Treatment Timecourse on Primary B cells.


ABSTRACT: The data describe the treatment of a human Primary B cells. The cells were treated with Rituximab and the full untargeted proteomics and transcriptomics were profiled over a total of 6 timepoints (0,1,2,4,7,15) hours. A validation experiment was repeated as a separate experiment using a subset of the time points.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: George I. Mias  

PROVIDER: MSV000081169 | MassIVE | Mon Jun 19 09:14:00 BST 2017

REPOSITORIES: MassIVE